Patent №
US 11,684,607
Granted
2023-06-27
Filed 2021
Owner
SYMBIOMIX THERAPEUTICS, LLC
+1 more
Lab
—
AI components
1
planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
17335016
Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
PlanningA61K 31/4164A61K 9/0053A61K 9/1676A61K 9/5078A61K 31/565A61K 31/567A61K 45/06A61P 5/30+5 more
AI classification
Planning0.58
Evolutionary computation0.01
Machine learning0.00
AI hardware0.00
Vision0.00
Speech0.00
Knowledge representation0.00
Natural language0.00
Ownership
SYMBIOMIX THERAPEUTICS, LLC
assignment · 573610222
LUPIN INC.
assignment · 573610328
Assignors
PENTIKIS, HELEN S., PALLING, DAVID, BRAUN, CAROL J.
On an employer assignment, the assignors are typically the inventors.